2026 Q1 Portfolio Activity
In 2026 Q1, SECTOR GAMMA AS maintained a portfolio of 47 distinct positions. The most significant new addition was UNITEDHEALTH GROUP INC, now representing 2.33% of the total fund value. They heavily accumulated shares in BRISTOL-MYERS SQUIBB CO, increasing the position by 11.0%. The fund also reduced its exposure to GILEAD SCIENCES INC by 69.8%.
Position History
hover any row below to update
Loading…
Total Positions
47
Quarter
2026 Q1
Top Holding
BMY (11.9%)
Top 10 Concentration
54.1%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
Showing 1-47 of 47
SECTOR GAMMA AS Full Holdings List — 2026 Q1
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
BMY
BRISTOL-MYERS S...
|
Healthcare | 11.86% | 9.17% |
#1
Prev: #1
|
8.0 |
—
|
81,946 | 11.0% |
P
S
|
827,901 | $50,212,196 | 2009 Q3 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
MRK
MERCK & CO INC
|
Healthcare | 7.39% | 8.73% |
#2
Prev: #2
|
4.5 |
—
|
-103,311 | -28.4% |
P
S
|
260,340 | $31,316,299 | 2011 Q1 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
PFE
PFIZER INC
|
Healthcare | 7.24% | 4.88% |
#3
4
Prev: #7
|
6.4 |
—
|
231,846 | 27.0% |
P
S
|
1,091,385 | $30,646,091 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
MDT
MEDTRONIC PLC
|
Healthcare | 5.74% | 5.90% |
#4
1
Prev: #3
|
3.3 |
—
|
11,038 | 4.1% |
P
S
|
280,682 | $24,321,095 | 2009 Q3 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
INCY
INCYTE CORP
|
Healthcare | 4.46% | 4.93% |
#5
1
Prev: #6
|
2.8 |
—
|
-18,273 | -8.4% |
P
S
|
200,510 | $18,872,001 | 2011 Q4 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
AMGN
AMGEN INC
|
Healthcare | 3.92% | 4.55% |
#6
2
Prev: #8
|
1.6 |
—
|
-13,801 | -22.6% |
P
S
|
47,155 | $16,591,487 | 2024 Q2 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
BIIB
BIOGEN INC
|
Healthcare | 3.90% | 3.43% |
#7
2
Prev: #9
|
3.6 |
—
|
4,621 | 5.4% |
P
S
|
90,096 | $16,517,300 | 2009 Q3 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
ZBH
ZIMMER BIOMET H...
|
Healthcare | 3.33% | 2.72% |
#8
7
Prev: #15
|
3.3 |
—
|
23,357 | 17.6% |
P
S
|
155,835 | $14,090,601 | 2009 Q3 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
BMRN
BIOMARIN PHARMA...
|
Healthcare | 3.20% | 2.69% |
#9
7
Prev: #16
|
3.8 |
—
|
41,413 | 20.9% |
P
S
|
239,918 | $13,552,968 | 2009 Q3 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
BDX
BECTON DICKINSO...
|
Healthcare | 3.07% | 5.86% |
#10
6
Prev: #4
|
1.2 |
—
|
-49,761 | -37.6% |
P
S
|
82,615 | $12,989,556 | 2020 Q4 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
ELV
ELEVANCE HEALTH...
|
Healthcare | 3.04% | 2.60% |
#11
6
Prev: #17
|
3.7 |
—
|
11,416 | 35.1% |
P
S
|
43,962 | $12,869,876 | 2016 Q2 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
IONS
IONIS PHARMACEU...
|
Healthcare | 3.00% | 3.34% |
#12
2
Prev: #10
|
1.7 |
—
|
-15,509 | -8.4% |
P
S
|
169,468 | $12,725,352 | 2017 Q4 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
CAH
CARDINAL HEALTH...
|
Healthcare | 2.74% | 2.90% |
#13
1
Prev: #12
|
1.6 |
—
|
-7,049 | -11.4% |
P
S
|
54,897 | $11,600,285 | 2009 Q3 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
UNH
UNITEDHEALTH GR...
|
Healthcare | 2.33% | — |
#14
Prev: #—
|
4.4 |
—
|
36,435 | — |
NEW
|
36,435 | $9,858,947 | 2009 Q3 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
CVS
CVS HEALTH CORP
|
Healthcare | 2.30% | 3.21% |
#15
4
Prev: #11
|
0.9 |
—
|
-42,262 | -23.8% |
P
S
|
135,337 | $9,719,903 | 2009 Q3 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
BRKR
BRUKER CORP
|
Healthcare | 2.17% | 2.73% |
#16
2
Prev: #14
|
1.4 |
—
|
-687 | -0.3% |
P
S
|
254,010 | $9,174,841 | 2019 Q2 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
GEHC
GE HEALTHCARE T...
|
Healthcare | 2.12% | 2.14% |
#17
2
Prev: #19
|
2.8 |
—
|
12,028 | 10.5% |
P
S
|
126,418 | $8,998,433 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
ABT
ABBOTT LABS
|
Healthcare | 2.12% | — |
#18
Prev: #—
|
4.3 |
—
|
87,532 | — |
NEW
|
87,532 | $8,986,910 | 2009 Q3 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
GILD
GILEAD SCIENCES...
|
Healthcare | 1.75% | 4.94% |
#19
14
Prev: #5
|
0.7 |
—
|
-123,167 | -69.8% |
P
S
|
53,247 | $7,421,034 | 2016 Q3 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
LNTH
LANTHEUS HLDGS ...
|
Healthcare | 1.67% | 1.42% |
#20
4
Prev: #24
|
1.2 |
—
|
-479 | -0.5% |
P
S
|
93,344 | $7,080,142 | 2023 Q2 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
IQV
IQVIA HLDGS INC
|
Healthcare | 1.62% | — |
#21
Prev: #—
|
4.1 |
—
|
40,230 | — |
NEW
|
40,230 | $6,860,824 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
SNDX
SYNDAX PHARMACE...
|
Healthcare | 1.58% | 1.21% |
#22
6
Prev: #28
|
2.6 |
—
|
33,945 | 13.5% |
P
S
|
286,007 | $6,681,124 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
BIO
BIO RAD LABS IN...
|
Healthcare | 1.56% | 1.64% |
#23
1
Prev: #22
|
1.6 |
—
|
no change | no change |
P
S
|
23,750 | $6,620,313 | 2013 Q2 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
N/A
QIAGEN NV
|
|
Unknown | 1.54% | — |
#24
Prev: #—
|
4.1 |
—
|
162,371 | — |
NEW
|
162,371 | $6,501,335 | — | 13F Filing | 2026-03-31 | 2026-05-07 | ||
|
AVTR
AVANTOR INC
|
Healthcare | 1.29% | 1.82% |
#25
4
Prev: #21
|
1.5 |
—
|
no change | no change |
P
S
|
695,403 | $5,451,960 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
CNC
CENTENE CORP DE...
|
Healthcare | 1.26% | 2.42% |
#26
8
Prev: #18
|
0.5 |
—
|
-95,704 | -37.1% |
P
S
|
162,405 | $5,317,140 | 2012 Q3 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
TNDM
TANDEM DIABETES...
|
Healthcare | 1.21% | 1.34% |
#27
2
Prev: #25
|
1.5 |
—
|
no change | no change |
P
S
|
267,091 | $5,120,134 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
PTCT
PTC THERAPEUTIC...
|
Healthcare | 1.21% | 1.07% |
#28
4
Prev: #32
|
3.0 |
—
|
13,077 | 21.1% |
P
S
|
75,000 | $5,109,750 | 2019 Q1 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
LH
LABCORP HOLDING...
|
Healthcare | 1.20% | 1.55% |
#29
6
Prev: #23
|
0.5 |
—
|
-8,000 | -29.6% |
P
S
|
19,019 | $5,074,459 | 2009 Q3 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
ASND
ASCENDIS PHARMA...
|
Healthcare | 1.15% | 0.79% |
#30
3
Prev: #33
|
3.0 |
—
|
5,000 | 30.7% |
P
S
|
21,305 | $4,873,093 | 2025 Q1 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
EW
EDWARDS LIFESCI...
|
Healthcare | 1.14% | 1.87% |
#31
11
Prev: #20
|
0.5 |
—
|
-36,000 | -37.3% |
P
S
|
60,402 | $4,836,992 | 2013 Q3 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
DXCM
DEXCOM INC
|
Healthcare | 0.83% | 1.15% |
#32
3
Prev: #29
|
0.3 |
—
|
-20,000 | -26.3% |
P
S
|
56,122 | $3,524,462 | 2025 Q2 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
CRNX
CRINETICS PHARM...
|
Healthcare | 0.81% | 1.22% |
#33
6
Prev: #27
|
0.8 |
—
|
-20,805 | -18.1% |
P
S
|
94,195 | $3,421,162 | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
KURA
KURA ONCOLOGY I...
|
Healthcare | 0.79% | 1.08% |
#34
3
Prev: #31
|
0.8 |
—
|
-44,031 | -9.7% |
P
S
|
411,810 | $3,348,015 | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
HUM
HUMANA INC
|
Healthcare | 0.79% | — |
#35
Prev: #—
|
3.8 |
—
|
19,202 | — |
NEW
|
19,202 | $3,329,435 | 2012 Q4 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
BBIO
BRIDGEBIO PHARM...
|
Healthcare | 0.78% | — |
#36
Prev: #—
|
3.8 |
—
|
44,263 | — |
NEW
|
44,263 | $3,286,970 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
IOVA
IOVANCE BIOTHER...
|
Healthcare | 0.75% | — |
#37
Prev: #—
|
3.8 |
—
|
900,000 | — |
NEW
|
900,000 | $3,159,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
DNLI
DENALI THERAPEU...
|
Healthcare | 0.74% | — |
#38
Prev: #—
|
3.8 |
—
|
162,710 | — |
NEW
|
162,710 | $3,124,032 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
ARDX
ARDELYX INC
|
Healthcare | 0.73% | — |
#39
Prev: #—
|
3.8 |
—
|
516,131 | — |
NEW
|
516,131 | $3,091,625 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
COGT
COGENT BIOSCIEN...
|
Healthcare | 0.73% | — |
#40
Prev: #—
|
3.8 |
—
|
80,000 | — |
NEW
|
80,000 | $3,079,200 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
OGN
ORGANON & CO
|
Healthcare | 0.53% | 0.49% |
#41
6
Prev: #35
|
2.7 |
—
|
75,974 | 25.3% |
P
S
|
375,974 | $2,252,084 | 2021 Q2 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
ARWR
ARROWHEAD PHARM...
|
Healthcare | 0.44% | — |
#42
Prev: #—
|
3.7 |
—
|
30,000 | — |
NEW
|
30,000 | $1,881,000 | 2026 Q1 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
CERT
CERTARA INC
|
Healthcare | 0.00% | 0.46% |
Sold All 😨
(Was: #36) |
0.0 |
—
|
-230,565 | -100.0% |
CLOSED
|
— | $— | 2025 Q3 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
CGON
CG ONCOLOGY INC
|
Healthcare | 0.00% | 0.49% |
Sold All 😨
(Was: #34) |
0.0 |
—
|
-52,039 | -100.0% |
CLOSED
|
— | $— | 2025 Q4 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
HCA
HCA HEALTHCARE ...
|
Healthcare | 0.00% | 1.15% |
Sold All 😨
(Was: #30) |
0.0 |
—
|
-10,784 | -100.0% |
CLOSED
|
— | $— | 2020 Q2 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
REGN
REGENERON PHARM...
|
Healthcare | 0.00% | 1.26% |
Sold All 😨
(Was: #26) |
0.0 |
—
|
-7,165 | -100.0% |
CLOSED
|
— | $— | 2018 Q2 | 13F Filing | 2026-03-31 | 2026-05-07 | |||
|
TMO
THERMO FISHER S...
|
Healthcare | 0.00% | 2.86% |
Sold All 😨
(Was: #13) |
0.0 |
—
|
-21,688 | -100.0% |
CLOSED
|
— | $— | 2009 Q3 | 13F Filing | 2026-03-31 | 2026-05-07 |
Showing 1-47 of 47 holdings